<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta id="journal-meta-da4c9e8001574e888796548c923f5ec8">
      <journal-id journal-id-type="nlm-ta">Sciresol</journal-id>
      <journal-id journal-id-type="publisher-id">Sciresol</journal-id>
      <journal-id journal-id-type="journal_submission_guidelines">https://ijpccr.com/#</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Preclinical &amp; Clinical Research</journal-title>
      </journal-title-group>
      <issn publication-format="electronic">2583-0104</issn>
      <issn publication-format="print"/>
    </journal-meta>
    <article-meta id="article-meta-af2460a6f6a44cf586096f86284b4577">
      <article-id pub-id-type="doi">10.51131/IJPCCR/v3i4.22.45</article-id>
      <article-categories>
        <subj-group>
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title id="article-title-99608366fb3d4bc6a094b58659b22096">
          <bold id="s-1ad6bd4ce2da">Neuromyelitis Optica Spectrum Disorder: A Rare Case Report</bold>
        </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name id="name-27c192ccac1d4694b14f067e52d6bbee">
            <surname>Sharanabasavaraja</surname>
            <given-names>B M</given-names>
          </name>
          <email>sharanabm@gmail.com</email>
          <xref id="xref-d1e61fbe7a1c4c94b8289ba915b63f92" rid="aff-bef4db07bf91463fa09a1b637d7b9f2d" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-1d03027eac904772ab02fd555002d808">
            <surname>Prashanth</surname>
            <given-names>G</given-names>
          </name>
          <xref id="x-64dfd667b8b5" rid="a-4d3eaff62e51" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-30229e6480844238b6038356159ba0ad">
            <surname>Kauser</surname>
            <given-names>M M</given-names>
          </name>
          <xref id="x-3f707373125d" rid="a-4d3eaff62e51" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-fe4cc30480464406970609b8b82a45be">
            <surname>Kumar</surname>
            <given-names>Vagesh</given-names>
          </name>
          <xref id="x-1a3097dd5bc1" rid="a-8259074dee0c" ref-type="aff">3</xref>
        </contrib>
        <aff id="aff-bef4db07bf91463fa09a1b637d7b9f2d">
          <institution>Junior Resident, Department of General Medicine, Basaveshwara Medical College and Hospital</institution>
          <addr-line>Chitradurga, Karnataka</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="a-4d3eaff62e51">
          <institution>Professor, Department of General Medicine, Basaveshwara Medical College and Hospital</institution>
          <addr-line>Chitradurga, Karnataka, 577502</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="a-8259074dee0c">
          <institution>Professor &amp; Head, Department of General Medicine, Basaveshwara Medical College and Hospital</institution>
          <addr-line>Chitradurga, Karnataka, 577502</addr-line>
          <country country="IN">India</country>
        </aff>
      </contrib-group>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>93</fpage>
      <permissions>
        <copyright-year>2022</copyright-year>
      </permissions>
      <abstract id="abstract-94d686a526fc">
        <title id="abstract-title-4a33f13d448f">Abstract</title>
        <p id="paragraph-8e5b0475b366">Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease that causes demyelination, especially in the optic nerve and spinal cord with typical manifestations of acute optic neuritis and transverse myelitis. 30-year-old male presented with complaints of breathlessness, sudden loss of vision and weakness of all four limbs since 2 days. On neurological examination found weakness in all four limbs with exaggerated deep tendon reflex. Blood tests were within normal limits. He was treated with pulse steroid therapy that is 1gm of methylprednisolone IV for 5 days but no improvement was noted. This is a case of neuromyelitis optica spectrum disorder which shown no improvement with pulse steroid therapy.</p>
        <p id="p-6bb136f99109"/>
      </abstract>
      <kwd-group id="kwd-group-789984e82b8b47e9a129cc211e463164">
        <title>Keywords</title>
        <kwd>Neuromyleitis optica</kwd>
        <kwd>Antibody</kwd>
        <kwd>Aquaporin-4</kwd>
      </kwd-group>
      <funding-group>
        <funding-statement>None</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title id="title-aff90f705fe344568e6e3a37c79aaf5f">Introduction</title>
      <p id="paragraph-94cdd6c43551487681938148ddd8230f">Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a rare chronic disorder of brain and spinal cord dominated by inflammation of optic nerve (optic neuritis) and inflammation of spinal cord (myelitis). The symptoms can occur simultaneously or separated by variable period <xref id="x-0200d5d5ca2a" rid="R162415026742919" ref-type="bibr">1</xref>. </p>
    </sec>
    <sec>
      <title id="t-e4fcba6aae44">Case report</title>
      <p id="paragraph-9f732737923a4a619a1fdc7dfc3819f9">30-year-old male presented with complaints of breathlessness, sudden loss of vision and weakness of all four limbs since 2 days. On neurological examination found weakness in all four limbs with exaggerated deep tendon reflex suggestive of involvement of corticospinal tract. Visual acuity on the right and left eyes showed absence of perception of light. Fundoscopic examination revealed bilateral optic atropy. MRI brain showed features suggestive of demyelination disorder. Blood tests were within normal limits. He was treated with pulse steroid therapy that is 1gm of methylprednisolone IV for 5 days but no improvement was noted.</p>
      <fig id="figure-08e0b469b23c42b499b5e1ad03e61482" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 1 </label>
        <caption id="caption-e7bcc69bd4e547eb82bafbfef39eb59c">
          <title id="title-711e92ef3a754266959040b489f648ce">MRI of brain</title>
        </caption>
        <graphic id="graphic-edcfccb82e6842c79aa214e8757ae680" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/f9e10191-f9a7-4c86-9869-f13c4e117826image1.png"/>
      </fig>
      <p id="p-9e933cdf06a6">﻿﻿</p>
    </sec>
    <sec>
      <title id="t-3117b09036fc">Discussion</title>
      <p id="paragraph-70755c2db6d1454fb9afbfd6b2a220b5">NMOSD is an autoimmune disease that causes severe demyelination. The pathogenesis of NMOSD is still not fully understand. Antibodies to AQP4 play a key role. AQP4 is a water channel that is mostly expressed on podocytes of astrocytic cell membrane forming part of the blood brain barrier.</p>
    </sec>
    <sec>
      <title id="title-e9daf014c9d745c18381ca824a969de8">Conclusion</title>
      <p id="paragraph-d2149d0a86a340a195242bd42a281a0a">This is a case of neuromyelitis optica spectrum disorder that showed no improvement with pulse steroid therapy.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R162415026742919">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname/>
              <given-names>Saif Huda</given-names>
            </name>
            <name>
              <surname>Whittam</surname>
              <given-names>Dan</given-names>
            </name>
            <name>
              <surname/>
              <given-names>Maneesh Bhojak</given-names>
            </name>
            <name>
              <surname/>
              <given-names>Jayne Chamberlain</given-names>
            </name>
            <name>
              <surname/>
              <given-names>Carmel Noonan</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>Anu</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Neuromyelitis optica spectrum disorders</article-title>
          <source>Clin Med (Lond)</source>
          <year>2019</year>
          <volume>19</volume>
          <issue>2</issue>
          <fpage>169</fpage>
          <lpage>176</lpage>
          <uri>https://doi.org/10.7861/clinmedicine.19-2-169</uri>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
